Werewolf Therapeutics Inc
Werewolf Therapeutics Inc logo
HOWL

Werewolf Therapeutics Inc (HOWL)

$4.110.49%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.1
Day's Range
$4.35
$3.42
52-Week Range
$21.67
1 month return0.98%
3 month return12.29%
1 year return72.16%
5 year return74.29%

Company Information

Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The company is leveraging its proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE™ molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment. Its most advanced product candidates, WTX-124 and WTX-330, are systemically delivered, conditionally activated Interleukin-2 (IL-2), and Interleukin-12 (IL-12) INDUKINE molecules for the treatment of solid tumors.The company is continuing preclinical studies for both WTX-124 and WTX-330 and expect to advance each candidate in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor.
OrganizationWerewolf Therapeutics Inc
CEO

Analyst Recommendation

based on 11 analysts ratings

Buy
90%
Buy
9%
Hold
0%
Sell

Based on 11 Wall street analysts offering stock ratings for Werewolf Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 672.95%

Current

$4.14

Target

$32.0

Recommendation Trend

Based on 11 analyst

Current1M Ago3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
111.7M
Book Value
5.53
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-10.94
Wall Street Target Price
22.8

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
0.79
Enterprise Value
-21023458
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.42

Technicals

50 Day MA
5.14
200 Day MA
12.2

Institutional Holdings

RA Capital Management, LLC

15.52%

Mpm Asset Management, LLC

15.49%

MPM Oncology Impact Management LP

8.64%

BlackRock Inc

4.61%

Adage Capital Partners Gp LLC

3.53%

Deerfield Management Co

3.46%

Discover more

Frequently Asked Questions

What is Werewolf Therapeutics Inc share price today?

Can Indians buy Werewolf Therapeutics Inc shares?

How can I buy Werewolf Therapeutics Inc shares from India?

Can Fractional shares of Werewolf Therapeutics Inc be purchased?

What are the documents required to start investing in Werewolf Therapeutics Inc stocks?

What are today’s High and Low prices of Werewolf Therapeutics Inc?

What are today’s traded volumes of Werewolf Therapeutics Inc?

What is today’s market capitalisation of Werewolf Therapeutics Inc?

What is the 52 Week High and Low Range of Werewolf Therapeutics Inc?

How much percentage Werewolf Therapeutics Inc is down from its 52 Week High?

How much percentage Werewolf Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Werewolf Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Werewolf Therapeutics Inc?